Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs.
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates
Today announced strategic collaboration with Hologen AI, including a $200 million upfront payment to MeiraGTx and the formation of a joint ...
BRICS+ Series: How Egypt is Revolutionising Africa's Pharmaceutical Industry
Egypt is transforming into Africa's pharmaceutical powerhouse, with 90% of drugs now produced locally. Through strategic ...
Amarin Corporation plc (NASDAQ:AMRN) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 12, 2025 Amarin Corporation plc beats earnings expectations. Reported EPS is $-0.03, expectations were $-0.06. Operator: Welcome to Amarin Corporation’s ...